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Novacor left ventricular assist system
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Partial aortic valve fusion induced by a left ventricularassist system (LVAS) has been reported by Rose andassociates.1 We report here a case of fish mouth–shapedaortic valve fusion induced by prolonged LVAS circu-
latory support.
Clinical Summary
A 48-year-old man first had congestive heart failure in 1994, and
medical treatment was initiated. In 1995, the heart failure wors-
ened despite medication, and the patient required hospitalization
and intensive treatment. Full examination of the patient led to the
diagnosis of idiopathic cardiomyopathy with an enlarged left ven-
tricle and depressed contractile function. Endomyocardial biopsy
showed findings compatible with idiopathic cardiomyopathy. The
patient’s heart failure improved with intensive treatment, and he
was discharged with enhanced medical therapy. In September
1997, the patient’s heart failure symptoms again gradually wors-
ened, and in December of that year he was brought to the emer-
gency department with cardiogenic shock. He was intubated,
placed on intra-aortic balloon pump support, and given a regimen
of the maximum dose of catecholamine, but his condition did not
improve despite this aggressive medical treatment. At that point no
aortic valve disease had been pointed out by either cardiac cathe-
terization or echocardiography. In March 1998 the patient was
transferred to Osaka University Hospital and underwent the place-
ment of a Novacor LVAS (World Heart Inc, Oakland, Calif). In
June 1998 the patient was qualified as a candidate for cardiac
transplantation by the institutional review board and the heart
transplantation committee of the Japanese Circulation Society, and
he was then registered with the Japan Organ Transplantation
Network. Our intention was to treat this as a bridge to transplan-
tation, although the legislation for organ transplantation is ex-
tremely strict in Japan,2,3 and the operational mode for the Novacor
LVAS was essentially set to fill-to-empty mode, which had been
keeping his aortic valve closed.
Because he was the first patient in Japan ever to be discharged
with LVAS support to await heart transplantation, the patient
repeated short leaves for 4 months and finally was discharged
home 7 months after LVAS implantation. While awaiting heart
transplantation, the patient enjoyed excellent quality of life at
home, except for a short hospital admission for a minor infection
in the drive line exit site. Serial echocardiography revealed no
functional recovery of his native heart. The anticoagulation regi-
men included coumadin and aspirin, and the patient’s condition
was fairly stable with a regimen of 3.5 to 4 mg coumadin, with an
international normalized ratio of 2.5 to 3.5. During the waiting for
heart transplantation, the patient did not have any thromboembolic
episodes. On February 26, 2001, after a wait on LVAS support for
1087 days, a brain-dead donor of identical blood type became
available and the patient underwent orthotopic cardiac transplan-
tation. The patient had hemodynamically compromised vascular
rejection, which was successfully treated with plasma exchange,
and he was discharged home on postoperative day 75 in good
physical and mental condition. After nearly 3 years, no degener-
ation was found in both inflow and outflow valves of the explanted
Novacor LVAS. Smooth and rigid peel formation was found inside
the inflow conduit. The explanted heart showed macroscopically
diffuse fibrosis in both ventricles and the intraventricular septum.
Interestingly, the aortic valve was fused between commissures and
only small opening was left (Figure 1). Histologic examination
revealed fibrous fusion between the commissures.
Discussion
Rose and associates1 reported partial aortic valve fusion induced
by LVAS. They found partial fusion of one or two aortic commis-
sures in 4 of 6 patients. After nearly 3 years of LVAS support in
automatic fill-to-empty mode, our patient’s aortic valve was fused
in all the commissures and had the shape of a fish mouth, although
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Figure 1. Fused aortic valve in explanted heart.
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no thrombi were found around the aortic valve. As far as we are
aware, there have been no previous reports describing the aortic valve
fusion of all three commissures, although Myers and colleagues4
reported complete fusion of a bioprosthetic valve in the aortic position
during several days of support with left heart bypass. This complica-
tion may become serious for the patients in whom LVAS acts as a
bridge to recovery or in those in whom LVAS fails. Fortunately,
neither was the case in our patient, but this complication should be
kept in mind for the patient supported by LVAS for an extended
period. Even though our patient was receiving the rather strict and
stable anticoagulant therapy recommended for the Novacor LVAS,
commissural fusion occurred. This phenomenon may occur more
easily with the HeartMate VE LVAS (Thoratec Corporation, Pleas-
anton, Calif) because that device requires less anticoagulant therapy.
Considering mechanical failure of LVAS, switching to the low-rate
fixed mode for several minutes at least once a day may be effective to
prevent aortic valve fusion of the native heart.
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